Your Search Results

A case-based approach: finding balance between bleeding and ischemic risk

19 May 2021 – From EuroPCR 2021

Watch this session presented by David Kandzari, Mirvat Alasnag, Emmanouil Brilakis, Chorcheung Frankie Tam and Beatriz Vaquerizo in order to debate case complexity of patient characteristics and complex lesions in HBR patients, to review patient centered clinical judgment and individualised treatment plans, and to analyse current Onyx ONE...

A case-based approach: finding balance between bleeding and ischemic risk

PCI of calcified coronaries - we will rock you! - Part 3

18 May 2021 – From EuroPCR 2021

Watch this session if you want to revisit strategies and devices for treatment of calcified plaque, to discuss the role of available options and to review in-depth procedural techniques for IntraVascular Lithotripsy.

This session was originally presented during EuroPCR 2021.

PCI of calcified coronaries - we will rock you! - Part 3

Revascularisation for chronic coronary syndrome and multivessel disease (Part 1) - Session with LIVE demonstration

18 May 2021 – From EuroPCR 2021

Watch this session if you want to understand when patients with CCS and MVD should undergo revascularisation, to appraise how to select the optimal revascularisation strategy in such patients and to learn how to perform state-of-the-art PCI to achieve optimal procedural outcomes.

This session was originally presented...

Revascularisation for chronic coronary syndrome and multivessel disease - Part 1

Revascularisation for chronic coronary syndrome and multivessel disease - Part 2

18 May 2021 – From EuroPCR 2021

Watch this session if you want to understand when patients with CCS and MVD should undergo revascularisation and to appraise how to select the optimal revascularisation strategy in such patients.

This session was originally presented during EuroPCR 2021.

Revascularisation for chronic coronary syndrome and multivessel disease - Part 2

Multivessel disease revascularisation: balancing the risk

19 May 2021 – From EuroPCR 2021

Watch this session presented by Jean Fajadet, Thomas Cuisset, Bruno Farah, Marek Grygier, Maciej Lesiak and Sylwia Iwanczyk in order to understand the selection of PCI for multivessel disease patients, to demonstrate the best treatment strategy for patients presenting with multivessel disease, and to discuss DAPT strategy in multivessel...

Multivessel disease revascularisation: balancing the risk

Challenges and opportunities in high-risk patients undergoing TAVI

19 May 2021 – From EuroPCR 2021

Watch this session presented by Marco Valgimigli, Raul Moreno and Peter Nordbeck in order to discuss the designing TAVI trial for high-risk patients, the timing of TAVI and PCI, as well as the balance between thrombosis prevention and bleeding mitigation

Challenges and opportunities in high-risk patients undergoing TAVI

EuroPCR 2021 Hotlines / Late-Breaking Trials in bifurcation lesions: EBC MAIN and more!

21 May 2021 – From EuroPCR 2021

Find out more about various studies & registries in bifurcation lesions:

EBC MAIN - the European Bifurcation Club Left Main Coronary Bifurcation Study
Clinical Outcomes after Physiology-Guided Treatment of Coronary Bifurcations

EuroPCR 2021 Hotlines / Late-Breaking Trials in bifurcation lesions: EBC MAIN and more!

MagicTouch sirolimus coated balloon continues to be the choice of treatment for CAD

19 May 2021 – From EuroPCR 2021

Watch this session presented by Antonio Colombo, Aloke Finn, Sandeep Basavarajaiah, Gianluca Caiazzo and Bernardo Cortese in order to know where to use a DCB in today's clinical practice, to learn about real-world case-based experience and interesting data presentation from various registries and clinical studies, and to understand the technology...

MagicTouch sirolimus coated balloon continues to be the choice of treatment for CAD

Advancing solutions for tricuspid regurgitation patients: introducing TriClip G4

19 May 2021 – From EuroPCR 2021

Watch this session presented by Francesco Maisano, Philipp Lurz, Fabien Praz, Patrizio Lancellotti and Georg Nickenig in order to learn about patient diagnosis and selection for tricuspid transcatheter treatment with TriClip, about latest clinical data supporting TriClip therapy, and about real life experience and attest product innovation: TriClip G4.

Advancing solutions for tricuspid regurgitation patients: introducing TriClip G4

Cardiovascular Innovation Pipeline: Transcatheter Mitral Replacement Devices

18 May 2021 – From EuroPCR 2021

Mitral regurgitation is a leading cause of valvular heart disease in Western countries. Transcatheter mitral valve replacement (TMVR) has emerged as a potential therapeutic option for patients with severe mitral disease who are at high risk for conventional surgery. Watch these presentations to find out about...